Immunovant (Nasdaq: IMVT) will report financial results for the third quarter on February 6, 2026, at 8:00 a.m. ET. To access the Roivant (Nasdaq: ROIV) conference call, register online using the provided link. The presentation details will be available on the Immunovant website under “News & Events” in the Investors section. Immunovant, Inc. is a clinical-stage immunology company focused on developing therapies for autoimmune diseases. For more information, visit immunovant.com. Contacts for investors and media are Keyur Parekh and Stephanie Lee, respectively.

Read more at GlobeNewswire: Immunovant to Report Financial Results for the Third